Pages

Wednesday, September 2, 2009

This guy was textn when he crossed the centerline - THIS IS BAD!!!!!!

WARNING****THESE PICS ARE GRAPHIC!

THE PICTURES SHOWN IN THIS EMAIL ARE GRAPHIC. PROCEED WITH CAUTION. HOWEVER THIS IS AN EYE OPENER TO US AND OUR LOVED ONES.. NEVER TEXT AND DRIVE!!!!!!!!!
Be aware!

These are terrible terrible pictures BUT pictures say a thousand words!
DO NOT TEXT and drive............even talking on the phone can distract!!!

This guy was texting a friend when he crossed the center line!!!!

Very very graphic!!!!!!

'How to Make a Trooper Cry'
WHY YOU SHOULD NOT BE TEXTING OR USING YOUR CELL PHONE WHILE DRIVING?




IF YOU HAVE A WEAK STOMACH STOP HERE!

The remaining pictures shows what happened to the body of the driver of the black vehicle. They are VERY graphic.
You've been warned
If you have a weak stomach you might to reconsider scrolling any further




Send this to everyone you care about
Even those that aren't driving yet.




































Justice Department Announces Largest Health Care Fraud

--------------------------------------------------------------------------------

FOR IMMEDIATE RELEASE
Wednesday, September 2, 2009
WWW.USDOJ.GOVAAG
(202) 514-2007
TDD (202) 514-1888

Justice Department Announces Largest Health Care Fraud Settlement in Its History
Pfizer to Pay $2.3 Billion for Fraudulent Marketing
WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together "Pfizer") have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department announced today.

Pharmacia & Upjohn Company has agreed to plead guilty to a felony violation of the Food, Drug and Cosmetic Act for misbranding Bextra with the intent to defraud or mislead. Bextra is an anti-inflammatory drug that Pfizer pulled from the market in 2005. Under the provisions of the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its new drug application to FDA. Once approved, the drug may not be marketed or promoted for so-called "off-label" uses – i.e., any use not specified in an application and approved by FDA. Pfizer promoted the sale of Bextra for several uses and dosages that the FDA specifically declined to approve due to safety concerns. The company will pay a criminal fine of $1.195 billion, the largest criminal fine ever imposed in the United States for any matter. Pharmacia & Upjohn will also forfeit $105 million, for a total criminal resolution of $1.3 billion.

In addition, Pfizer has agreed to pay $1 billion to resolve allegations under the civil False Claims Act that the company illegally promoted four drugs – Bextra; Geodon, an anti-psychotic drug; Zyvox, an antibiotic; and Lyrica, an anti-epileptic drug – and caused false claims to be submitted to government health care programs for uses that were not medically accepted indications and therefore not covered by those programs. The civil settlement also resolves allegations that Pfizer paid kickbacks to health care providers to induce them to prescribe these, as well as other, drugs. The federal share of the civil settlement is $668,514,830 and the state Medicaid share of the civil settlement is $331,485,170. This is the largest civil fraud settlement in history against a pharmaceutical company.

As part of the settlement, Pfizer also has agreed to enter into an expansive corporate integrity agreement with the Office of Inspector General of the Department of Health and Human Services. That agreement provides for procedures and reviews to be put in place to avoid and promptly detect conduct similar to that which gave rise to this matter.

Whistleblower lawsuits filed under the qui tam provisions of the False Claims Act that are pending in the District of Massachusetts, the Eastern District of Pennsylvania and the Eastern District of Kentucky triggered this investigation. As a part of today’s resolution, six whistleblowers will receive payments totaling more than $102 million from the federal share of the civil recovery.

The U.S. Attorney’s offices for the District of Massachusetts, the Eastern District of Pennsylvania, and the Eastern District of Kentucky, and the Civil Division of the Department of Justice handled these cases. The U.S. Attorney’s Office for the District of Massachusetts led the criminal investigation of Bextra. The investigation was conducted by the Office of Inspector General for the Department of Health and Human Services (HHS), the FBI, the Defense Criminal Investigative Service (DCIS), the Office of Criminal Investigations for the Food and Drug Administration (FDA), the Veterans’ Administration’s (VA) Office of Criminal Investigations, the Office of the Inspector General for the Office of Personnel Management (OPM), the Office of the Inspector General for the United States Postal Service (USPS), the National Association of Medicaid Fraud Control Units and the offices of various state Attorneys General.

"Today’s landmark settlement is an example of the Department of Justice’s ongoing and intensive efforts to protect the American public and recover funds for the federal treasury and the public from those who seek to earn a profit through fraud. It shows one of the many ways in which federal government, in partnership with its state and local allies, can help the American people at a time when budgets are tight and health care costs are increasing," said Associate Attorney General Tom Perrelli. "This settlement is a testament to the type of broad, coordinated effort among federal agencies and with our state and local partners that is at the core of the Department of Justice’s approach to law enforcement."

"This historic settlement will return nearly $1 billion to Medicare, Medicaid, and other government insurance programs, securing their future for the Americans who depend on these programs," said Kathleen Sebelius, Secretary of Department of Health and Human Services. "The Department of Health and Human Services will continue to seek opportunities to work with its government partners to prosecute fraud wherever we can find it. But we will also look for new ways to prevent fraud before it happens. Health care is too important to let a single dollar go to waste."

"Illegal conduct and fraud by pharmaceutical companies puts the public health at risk, corrupts medical decisions by health care providers, and costs the government billions of dollars," said Tony West, Assistant Attorney General for the Civil Division. "This civil settlement and plea agreement by Pfizer represent yet another example of what penalties will be faced when a pharmaceutical company puts profits ahead of patient welfare."

"The size and seriousness of this resolution, including the huge criminal fine of $1.3 billion, reflect the seriousness and scope of Pfizer’s crimes," said Mike Loucks, acting U.S. Attorney for the District of Massachusetts. "Pfizer violated the law over an extensive time period. Furthermore, at the very same time Pfizer was in our office negotiating and resolving the allegations of criminal conduct by its then newly acquired subsidiary, Warner-Lambert, Pfizer was itself in its other operations violating those very same laws. Today’s enormous fine demonstrates that such blatant and continued disregard of the law will not be tolerated."

"Although these types of investigations are often long and complicated and require many resources to achieve positive results, the FBI will not be deterred from continuing to ensure that pharmaceutical companies conduct business in a lawful manner," said Kevin Perkins, FBI Assistant Director, Criminal Investigative Division.

"This resolution protects the FDA in its vital mission of ensuring that drugs are safe and effective. When manufacturers undermine the FDA’s rules, they interfere with a doctor’s judgment and can put patient health at risk," commented Michael L. Levy, U.S. Attorney for the Eastern District of Pennsylvania. "The public trusts companies to market their drugs for uses that FDA has approved, and trusts that doctors are using independent judgment. Federal health dollars should only be spent on treatment decisions untainted by misinformation from manufacturers concerned with the bottom line."

"This settlement demonstrates the ongoing efforts to pursue violations of the False Claims Act and recover taxpayer dollars for the Medicare and Medicaid programs," noted Jim Zerhusen, U.S. Attorney for the Eastern District of Kentucky.

"This historic settlement emphasizes the government’s commitment to corporate and individual accountability and to transparency throughout the pharmaceutical industry," said Daniel R. Levinson, Inspector General of the United States Department of Health and Human Services. "The corporate integrity agreement requires senior Pfizer executives and board members to complete annual compliance certifications and opens Pfizer to more public scrutiny by requiring it to make detailed disclosures on its Web site. We expect this agreement to increase integrity in the marketing of pharmaceuticals."

"The off-label promotion of pharmaceutical drugs by Pfizer significantly impacted the integrity of TRICARE, the Department of Defense’s healthcare system," said Sharon Woods, Director, Defense Criminal Investigative Service. "This illegal activity increases patients’ costs, threatens their safety and negatively affects the delivery of healthcare services to the over nine million military members, retirees and their families who rely on this system. Today’s charges and settlement demonstrate the ongoing commitment of the Defense Criminal Investigative Service and its law enforcement partners to investigate and prosecute those that abuse the government’s healthcare programs at the expense of the taxpayers and patients."

"Federal employees deserve health care providers and suppliers, including drug manufacturers, that meet the highest standards of ethical and professional behavior," said Patrick E. McFarland, Inspector General of the U.S. Office of Personnel Management. "Today’s settlement reminds the pharmaceutical industry that it must observe those standards and reflects the commitment of federal law enforcement organizations to pursue improper and illegal conduct that places health care consumers at risk."

"Health care fraud has a significant financial impact on the Postal Service. This case alone impacted more than 10,000 postal employees on workers’ compensation who were treated with these drugs," said Joseph Finn, Special Agent in Charge for the Postal Service’s Office of Inspector General. "Last year the Postal Service paid more than $1 billion in workers’ compensation benefits to postal employees injured on the job."

###

09-900


http://www.usdoj.gov/opa/pr/2009/September/09-aag-900.html





Health Blog

By Shirley S. Wang
You may remember something about the $2.3 billion that Pfizer said it is paying to settle a Justice Department probe into accusations of off-label marketing of painkiller Bextra, which is now off the market. That news was buried with the announcement in January that Pfizer was buying rival drug maker Wyeth.

Today the details of the settlement were released and they are harsh: Pfizer agreed to plead guilty to a felony violation “for misbranding Bextra with the intent to defraud or mislead.” The settlement is the largest in Justice Department history, according to the DOJ’s statement.

It will pay a criminal fine of just over $1 billion, which the DOJ says is the largest ever imposed in the U.S. for any reason. The company will also pay $1 billion to resolve civil allegations that the company illegally marketed Bextra, the psychiatric drug Geodon, antibiotic Zyvox and anti-epileptic drug Lyrica.

And, the company agreed to an “expansive corporate integrity agreement” with the Office of Inspector General of the Department of Health and Human Services to establish procedures and reviews to detect and avoid similar matters in the future, said the DOJ.

“We regret certain actions taken in the past, but are proud of the action we’ve taken to strengthen our internal controls and pioneer new procedures so that we not only comply with state and federal laws, but also meet the high standards that patients, physicians and the public expect from a leading worldwide company dedicated to healing and better health,” Pfizer’s general counsel Amy W. Schulman said in a statement.

Tuesday, September 1, 2009

The Prevention of Farm Animal Cruelty Act Documentary

Four UCI students worked together to create this film for our Political Science 21A: Intro to American Government class. We set out to uncover why voting yes on this act would benefit animals in California and hopefully be used as the starting block for a nationwide campaign.



This act did pass, more info on what is has helped so far.

Undercover Investigation at Hy-Line Hatchery

Saturday, August 29, 2009

WHO'S SKIN ARE YOU IN?



We can stop the cruelty just buy pleather, cotton, hemp and synthetic's
I'll have to post more about this and post some websites for clothing and accessories.


Here's some great info:
Every company listed here manufactures
products that are not tested on animals

A company that manufactures
strictly vegan products—made
without animal-derived ingredients,
such as honey, beeswax, milk and
egg byproducts, lanolin, or
slaughterhouse byproducts.

Download this pdf pamphlet

http://www.petaliterature.com/VIV236.pdf

Undercover Video Shows Rabbits Screaming During Slaughter


Find out more about Armani on peta.org.



Lets try to do something about this its just not right we dont need the fur or leather neither, lets all try to use alternatives.
I will tryt to post some websites where you can buy plant based clothing.

Friday, August 28, 2009

Autism

Donna Gates
Body Ecology
Donna Gates shares her insights on the causes, prevention and solutions for this epidemic with a focus on detoxification, removing offending environmental catalysts, and healing the gut through correcting diet and the use of probiotics.

Thursday, August 27, 2009

INFORMED CHOICE - Cocktail Vaccinations

INFORMED CHOICE - Cocktail


Check out these wesites also:

http://www.thinktwice.com/studies.htm
http://www.youtube.com/user/ginahctsun#play/playlists


INFORMED CHOICE
Vaccine Ingredients
In a compulsory inoculation program, it is the responsibility of the developers, promoters and enforcers to prove safety and efficacy
a representative sample
Vaccine Manufacturer Microbes Antibiotics Chemicals / Heavy Metals Animal ByProducts
Acel-Immune DTaP
diphtheria - tetanus - pertussis Wyeth-Ayerst
800.934.5556 diphtheria and tetanus toxoids and acellular pertussis adsorbed formaldehyde, aluminum hydroxide, aluminum phosphate, thimerosal, and polysorbate 80 (Tween-80) gelatin
Act HIB

Haemophilus influenza
Type B Connaught Laboratories
800.822.2463 Haemophilus influenza
Type B, polyribosylribitol phosphate ammonium sulfate, formalin, and sucrose
Attenuvax
measles Merck & Co., Inc.
800-672-6372 measles live virus neomycin sorbitol hydrolized gelatin, chick embryo
Biavax
rubella Merck & Co., Inc.
800-672-6372 rubella live virus neomycin sorbitol hydrolized gelatin, human diploid cells from aborted fetal tissue
BioThrax
anthrax adsorbed BioPort Corporation 517.327.1500 nonencapsulated strain of
Bacillus anthracis aluminum hydroxide, benzethonium chloride, and formaldehyde
DPT
diphtheria - tetanus - pertussis GlaxoSmithKline 800.366.8900
X 5231 diphtheria and tetanus toxoids and acellular pertussis adsorbed formaldehyde, aluminum phosphate, ammonium sulfate, and thimerosal washed sheep RBCs
Dryvax
smallpox
(not licensed d/t expiration) Wyeth-Ayerst
800.934.5556 live vaccinia virus, with "some microbial contaminants," according to the Working Group on Civilian Biodefense polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate glycerin, and phenol -a compound obtained by distillation of coal tar vesicle fluid from calf skins
Engerix-B
recombinant hepatitis B GlaxoSmithKline 800.366.8900
X 5231 genetic sequence of the hepatitis B virus that codes for the surface antigen (HbSAg), cloned into GMO yeast aluminum hydroxide, and thimerosal
Fluvirin
Medeva Pharmaceuticals 888.MEDEVA 716.274.5300 influenza virus neomycin, polymyxin beta-propiolactone chick embryonic fluid
FluShield
Wyeth-Ayerst
800.934.5556 trivalent influenza virus, types A&B gentamicin sulphate formadehyde, thimerosal, and polysorbate 80 (Tween-80) chick embryonic fluid
Havrix
hepatitis A GlaxoSmithKline 800.366.8900
X 5231 hepatitis A virus formalin, aluminum hydroxide, 2-phenoxyethanol, and polysorbate 20 residual MRC5 proteins -human diploid cells from aborted fetal tissue
HiB Titer

Haemophilus influenza
Type B Wyeth-Ayerst
800.934.5556 Haemophilus influenza
Type B,
polyribosylribitol phosphate, yeast ammonium sulfate, thimerosal, and chemically defined yeast-based medium
Imovax
Connaught Laboratories 800.822.2463 rabies virus adsorbed neomycin sulfate phenol red indicator human albumin, human diploid cells from aborted fetal tissue
IPOL
Connaught Laboratories 800.822.2463 3 types of polio viruses neomycin, streptomycin, and polymyxin B formaldehyde, and 2-phenoxyethenol continuous line of monkey kidney cells
JE-VAX
Japanese encephalitis Aventis Pasteur USA
800.VACCINE Nakayama-NIH
strain of Japanese encephalitis virus, inactivated formaldehyde, polysorbate 80 (Tween-80), and thimerosal mouse serum proteins, and gelatin
LYMErix
lyme GlaxoSmithKline
888-825-5249 recombinant protein (OspA) from the outer surface of the spirochete
Borrelia burgdorferi kanamycin aluminum hydroxide, 2-phenoxyethenol, phosphate buffered saline
MMR
measles - mumps - rubella Merck & Co., Inc.
800.672.6372 measles, mumps, rubella live virus neomycin sorbitol hydrolized gelatin, chick embryonic fluid, and human diploid cells from aborted fetal tissue
M-R-Vax
measles - rubella Merck & Co., Inc.
800.672.6372 measles, rubella live virus neomycin sorbitol hydrolized gelatin, chick embryonic fluid, and human diploid cells from aborted fetal tissue
Menomune
meningococcal Connaught Laboratories 800.822.2463 freeze-dried polysaccharide antigens from
Neisseria meningitidis
bacteria thimerosal lactose
Meruvax I
mumps Merck & Co., Inc.
800.672.6372 mumps live virus neomycin sorbitol hydrolized gelatin
NYVAC
(new smallpox batch, not licensed) Aventis Pasteur USA
800.VACCINE highly attenuated vaccinia virus polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate glycerin, and phenol -a compound obtained by distillation of coal tar vesicle fluid from calf skins
Orimune
oral polio Wyeth-Ayerst
800.934.5556 3 types of polio viruses, attenuated neomycin, streptomycin sorbitol monkey kidney cells and calf serum
Pneumovax

Streptococcus pneumoniae Merck & Co., Inc.

800.672.6372 capsular polysaccharides from polyvalent (23 types) pneumococcal bacteria phenol
Prevnar
Pneumococcal 7-valent conjugate vaccine Wyeth Lederle
800.934.5556 saccharides from capsular
Streptococcus pneumoniae
antigens (7 serotypes) individually conjugated to diphtheria CRM 197 protein aluminum phosphate, ammonium sulfate, soy protein, yeast
ProQuad
measles, mumps, rubella and varicella Merck & Co., Inc.
800.672.6372 live measles (Enders' attenuated Edmonston), mumps (Jeryl LynnTM), rubella (Wistar RA 27/3), and varicella (oka/Merck) strains of viruses neomycin monosodium L-glutamate (MSG), potassium chloride, potassium phosphate monobasic, potassium phosphate dibasic, sodium bicarbonate, sodium phosphate dibasic, sorbitol, and sucrose human albumin, human diploid cells, residual components of MRC-5 cells including DNA and proteins, bovine serum, hydrolized gelatin, and chicken embryo
RabAvert
rabies Chiron Behring GmbH & Company
510.655.8729 fixed-virus strain Flury LEP neomycin, chlortetracycline, and amphotericin B potassium glutamate, and sucrose human albumin, bovine gelatin and serum "from source countries known to be free of bovine spongioform encephalopathy," and chicken protein
Rabies Vaccine Adsorbed
GlaxoSmithKline 800.366.8900
X 5231 rabies virus adsorbed beta-propiolactone, aluminum phosphate, thimerosal, and phenol red rhesus monkey fetal lung cells
Recombivax
recombinant hepatitis B Merck & Co., Inc.
800.672.6372 genetic sequence of the hepatitis B virus that codes for the surface antigen (HbSAg), cloned into GMO yeast aluminum hydroxide, and thimerosal
RotaShield
oral tetravalent rotavirus (recalled) Wyeth-Ayerst
800.934.5556 1 rhesus monkey rotavirus, 3 rhesus-human reassortant live viruses neomycin sulfate, amphotericin B potassium monophosphate, potassium diphosphate, sucrose, and monosodium glutamate (MSG) rhesus monkey fetal diploid cells, and bovine fetal serum
smallpox
(not licensed due to expiration) 40-yr old stuff "found" in Swiftwater, PA freezer Aventis Pasteur USA
800.VACCINE live vaccinia virus, with "some microbial contaminants," according to the Working Group on Civilian Biodefense polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate glycerin, and phenol -a compound obtained by distillation of coal tar vesicle fluid from calf skins
smallpox
(new, not licensed) Acambis, Inc.
617.494.1339
in partnership with Baxter BioScience highly attenuated vaccinia virus polymyxcin B sulfate, streptomycin sulfate, chlortetracycline hydrochloride, and neomycin sulfate glycerin, and phenol -a compound obtained by distillation of coal tar vesicle fluid from calf skins
TheraCys BCG
(intravesicle -not licensed in US for tuberculosis) Aventis Pasteur USA
USA 800.VACCINE live attenuated strain of
Mycobacterium bovis monosodium glutamate (MSG), and polysorbate 80 (Tween-80)
Tripedia
diphtheria - tetanus - pertussis Aventis Pasteur USA
800.VACCINE Corynebacterium diphtheriae
and
Clostridium tetani
toxoids and acellular
Bordetella pertussis
adsorbed aluminum potassium sulfate, formaldehyde, thimerosal, and polysorbate 80 (Tween-80) gelatin, bovine extract US sourced
Typhim Vi
typhoid Aventis Pasteur USA SA
800.VACCINE cell surface Vi polysaccharide from
Salmonella typhi
Ty2 strain aspartame, phenol, and polydimethylsiloxane (silicone)
Varivax
chickenpox Merck & Co., Inc.
800.672.6372 varicella live virus neomycin phosphate, sucrose, and monosodium glutamate (MSG) processed gelatin, fetal bovine serum, guinea pig embryo cells, albumin from human blood, and human diploid cells from aborted fetal tissue
YF-VAX
yellow fever Aventis Pasteur USA
800.VACCINE 17D strain of yellow fever virus sorbitol chick embryo, and gelatin

home
screening
Disclaimer / Investigate: The intent of this website is to raise awareness about the controversial aspects of vaccination. Many vaccines still contain thimerosal (49.6% ethylmercury by weight.) While mercury is a highly toxic element second only to radioactive plutonium, when combined with other ingredients, specifically aluminum and formaldehyde, the synergistic effects increase 10,000-fold. Individuals who suffer from chronic mercury exposure will have a unique expression of symptoms. This presentation is not to be construed as medical or legal advice: locate and confer with a trusted physician and lawyer.






http://www.youtube.com/user/ginahctsun#play/playlists


Also check out http://www.thinktwice.com/studies.htm


www.informedchoice.info

Tuesday, August 25, 2009

Texting while Driving

A MUST WATCH



A HARD-hitting drama showing the dangers of texting while driving. “Cow” is the story of Cassie Cowan, who takes her eyes off the road for a split second, leading to a fatal collision, which has profound affects on her, her family and the families of her victims. The film was a co-production between Tredegar Comprehensive School and Gwent Police. If you have more information, please post it below the video.



U.K., August 2009, Peter Watkins-Hughes - Newport School of AMD, Wales


** YouTube Summary Written by David Kusumoto. ** In the United Kingdom, a graphic public service film depicting the ravages of using cell phones in cars has spread virally on the Internet. (Com...